HARMONY BIOSCIENCES ANNOUNCES POSITIVE PHASE 2 SIGNAL DETECT

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...

Related Keywords

Colorado , United States , Denver , Orlando , Florida , Americans , Kumar Budur , Susan Hedstrom , Luis Sanay , Paige Rivard , Foundation For Prader Willi Research , Paragon Biosciences , Research Symposium , United States National Convention In Orlando , Prnewswire Harmony Biosciences Holdings Inc , Drug Administration , Exchange Commission , Prader Willi Syndrome Association United States , Biosciences Holdings , Annual Meeting , Associated Professional Sleep Societies , Epworth Sleepiness Scale , Chief Medical Officer , Executive Director , Prader Willi Research , Chief Executive Officer , Prader Willi Syndrome Association , National Convention , Family Conference , Primary Efficacy , Safety Results , Placebo Controlled Proof , Signal Detection Study , Serious Adverse Events , Full Prescribing Information , Harmony Biosciences , Plymouth Meeting , Private Securities Litigation Reform Act , Annual Report , Biosciences Media Contact , Biosciences Investor Contact ,